MARKET

XTLB

XTLB

X T L Bio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9958
+0.0058
+0.59%
Closed 16:00 04/03 EDT
OPEN
1.000
PREV CLOSE
0.9900
HIGH
1.000
LOW
0.9958
VOLUME
249
TURNOVER
--
52 WEEK HIGH
2.680
52 WEEK LOW
0.6250
MARKET CAP
512.05K
P/E (TTM)
1.660
1D
5D
1M
3M
1Y
5Y

EPS

XTLB News

More
  • The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission
  • Benzinga · 12/05/2019 12:14
  • The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon
  • Benzinga · 11/21/2019 12:22
  • The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
  • Benzinga · 11/15/2019 12:08
  • The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
  • Benzinga · 11/13/2019 12:10

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About XTLB

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
More

Webull offers kinds of X T L Biopharmaceuticals Ltd (ADR) stock information, including NASDAQ:XTLB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTLB stock news, and many more online research tools to help you make informed decisions.